publication venue for
- Intravenous and subcutaneous vedolizumab for moderately to severely active ulcerative colitis in Iran: a model-based cost-effectiveness evaluation.. 25:933-941. 2025
- Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review.. 23:1-11. 2023
- Prescription drug coverage satisfaction and medication nonadherence among Medicare beneficiaries with cancer.. 22:1-9. 2022